title: Management of scabies.
abstract: Scabies is a common contagious parasitic dermatosis. Transmission of the mite Sarcoptes scabiei var hominis generally occurs by skin-to-skin contact, but with crusted scabies it may also occur through fomites, such as infected clothing or bedding. Diagnosis is usually clinical. A 2010 updated Cochrane review concluded that management of scabies is based on topical scabicides, mainly 5% permethrin. However, oral ivermectin, although not licensed in many countries, may be useful, particularly for patients who cannot tolerate or comply with topical therapy and in institutional scabies epidemics. Patients should also receive detailed information about the infestation to limit further spreading. Cases resulting from close physical or sexual contact, even without symptoms, should be systematically treated. Hygienic measures should be taken after treatment is completed. Patients should be followed to confirm cure, including resolution of itching, which may take up to 4 weeks or longer.
authors.affiliation: Department of Dermatology, Saint Louis Hospital, Paris, France.
authors.forename: Gentiane
authors.initials: G
authors.lastname: Monsel
authors.forename: Olivier
authors.initials: O
authors.lastname: Chosidow
mesh_terms: D000818:Animals; D000977:Antiparasitic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007306:Insecticides / Q000008:administration & dosage / Q000627:therapeutic use*; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use*; D026023:Permethrin / Q000008:administration & dosage / Q000627:therapeutic use*; D012532:Scabies / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission
chemical_list: D000977:Antiparasitic Agents; D007306:Insecticides; D026023:Permethrin; D007559:Ivermectin